Ochsner Health sends out guidance on pregnancy medication ahead of new law - wwno.org
Ochsner Health provides guidance on pregnancy medication in anticipation of a new law affecting medication dispensing practices.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 3, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Pharmacy & Controlled Substances move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.
What changed
New guidance on pregnancy medication dispensing ahead of upcoming legal changes.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies.
What you must do
Review and implement the new guidance on pregnancy medication as per the upcoming law.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- New Maine law recognizes pharmacists as health care providers - une.edu
- Florida pharmacists receive approval to provide COVID-19 vaccines - wusf.org
- Express Scripts Launches Court Fight on Arkansas Pharmacy Law - news.bloomberglaw.com
- Determination That PHENAPHEN WITH CODEINE NO. 3 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 30 Milligrams, and PHENAPHEN WITH CODEINE NO. 4 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 60 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Pharmacies may violate civil rights if they refuse meds linked to abortion, feds warn - NPR